You are here

Novo Nordisk

J&J, Novo support Asgard’s push to make ‘in vivo’ cell therapies

BioPharma Dive

Thu, 03/14/24 - 11:31 am

Asgard Therapeutics

in vivo cell therapy

How the Ozempic gold rush is causing ‘deeply concerning’ shortage for diabetes patients

Biopharma Reporter

Wed, 03/13/24 - 11:16 am

Novo Nordisk-owner to expand in India this year

Reuters

Tue, 03/12/24 - 06:50 pm

Novo Nordisk working with global authorities to take down fake Ozempic

Beckers Hospital Review

Mon, 03/11/24 - 05:03 pm

drug counterfeiting

FDA clears use of Novo’s obesity drug to protect heart health

BioPharma Dive

Sun, 03/10/24 - 08:43 pm

Novo Nordisk confident of amycretin obesity drug launch this decade

Reuters

Fri, 03/8/24 - 11:09 am

Launches and prices of Novo Nordisk's weight-loss drug Wegovy

Reuters

Fri, 03/8/24 - 10:59 am

Novo valuation surpasses Tesla on experimental obesity drug data

Reuters

Thu, 03/7/24 - 11:40 am

clinical trials

Novo kidney trial finds Ozempic cuts cardiac risks in diabetics

Reuters

Tue, 03/5/24 - 11:52 am

clinical trials

chronic kidney disease

Novo Nordisk's new Boston-area campus reflects 'competitive' R&D growth, and not just for GLP-1s

Fierce Biotech

Thu, 02/29/24 - 11:16 am

Novo Nordisk doles out $1.4B for molecular glue degraders licensing pact

Medical Marketing and Media

Mon, 02/26/24 - 05:18 pm

molecular glue degraders

Weight-loss drugs could boost US GDP by 1% in coming years, Goldman says

Reuters

Thu, 02/22/24 - 11:14 pm

Novo Nordisk, Eli Lilly lead industrywide sales surge in Q4

Fierce Pharma

Thu, 02/22/24 - 11:12 pm

Novo, Novartis, BMS and J&J win judge's blessing to combine arguments in upcoming IRA hearing

Fierce Pharma

Wed, 02/21/24 - 11:25 am

Bristol Myers Squibb

Inflation Reduction Act

Actually Wegovy is good for dialysis companies, dialysis provider says

Stat

Wed, 02/21/24 - 11:12 am

Fresenius Medical Care

Lilly Edges Out J&J to Top 20 BioPharma Market Cap List for 2023

BioSpace

Tue, 02/20/24 - 05:55 pm

Novo Nordisk and Catalent deal: net positive or negative for industry?

Biopharma Reporter

Tue, 02/20/24 - 11:06 am

Wegovy fuels sharp rise in use of weight-loss drugs for US youth

Reuters

Thu, 02/15/24 - 07:24 pm

Weight loss drugs like Ozempic have food CEOs so 'scared' they're calling Novo Nordisk for advice

Quartz

Thu, 02/15/24 - 07:20 pm

Lars Fruergaard Jorgensen

3 questions hanging over the Novo-Catalent deal

Pharma Voice

Wed, 02/14/24 - 10:55 am

drug manufacturing

Pages